The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target
Article in Inflammation Research (March 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Inflammation Research (March 2024)
Article in Critical Reviews in Immunology (January 2024)
Article in Gout, Urate, and Crystal Deposition Disease (December 2023)